Which of the following active surveillance screening cultures would be appropriate for carbapenem-resistant Enterobacterales (previously known as carbapenem-resistant Enterobacteriaceae) (CRE)?
Correct Answer: A
Carbapenem-resistant Enterobacterales (CRE) colonization is most commonly found in the gastrointestinal (GI) tract. Therefore, rectal or peri-rectal cultures are recommended for active surveillance screening. Why the Other Options Are Incorrect? * B. Nares or axillary cultures - CRE is not primarily found in the nasal or axillary region; this method is more relevant for detecting MRSA. * C. Abscess or blood cultures - While CRE may be present in clinical infections, these cultures are not used for screening asymptomatic carriers. * D. Throat or nasopharyngeal cultures - CRE does not commonly colonize the upper respiratory tract, so these are not ideal for active screening. CBIC Infection Control Reference The CDC and APIC guidelines emphasize rectal or peri-rectal swabbing as the most effective active surveillance method for CRE detection.
Question 37
The infection preventionist (IP) is assisting pharmacists in investigating medication contamination at the hospital's compounding pharmacy. As part of the medication recall process, the IP should:
Correct Answer: C
The scenario involves an infection preventionist (IP) assisting pharmacists in addressing medication contamination at the hospital's compounding pharmacy, with a focus on the medication recall process. The IP' s role is to apply infection control expertise to mitigate risks, guided by the Certification Board of Infection Control and Epidemiology (CBIC) principles and best practices. The recall process requires a systematic approach to identify, contain, and resolve the issue, and the "first" or most critical step must be determined. Let's evaluate each option: A). Have laboratory culture all medication: Culturing all medication to confirm contamination is a valuable step to identify affected batches and guide the recall. However, this is a resource-intensive process that depends on first understanding the scope and source of the problem. Without identifying the potential source of contamination, culturing all medication could be inefficient and delay the recall. This step is important but secondary to initial investigation. B). Inspect for safe injection practices: Inspecting for safe injection practices (e.g., single-use vials, proper hand hygiene, sterile technique) is a critical infection control measure, especially in compounding pharmacies where contamination often arises from procedural errors (e.g., reuse of syringes, improper cleaning). While this is a proactive step to prevent future contamination, it addresses ongoing practices rather than the immediate recall process for the current contamination event. It is a complementary action but not the first priority. C). Identify the potential source of contamination: Identifying the potential source of contamination is the foundational step in the recall process. This involves investigating the compounding environment (e.g., water quality, equipment, personnel practices), raw materials, and production processes to pinpoint where the contamination occurred (e.g., bacterial ingress, cross-contamination). The CBIC emphasizes root cause analysis as a key infection prevention strategy, enabling targeted recalls, corrective actions, and prevention of recurrence. This step is essential before culturing, inspecting, or notifying patients, making it the IP's primary responsibility in this context. D). Inform all discharged patients of potential medication contamination: Notifying patients is a critical step to ensure public safety and allow for medical follow-up if they received contaminated medication. However, this action requires prior identification of the contaminated batches and their distribution, which depends on determining the source and confirming the extent of the issue. Premature notification without evidence could cause unnecessary alarm and is not the first step in the recall process. The best answer is C, as identifying the potential source of contamination is the initial and most critical step in the medication recall process. This allows the IP to collaborate with pharmacists to trace the contamination, define the affected products, and guide subsequent actions (e.g., culturing, inspections, notifications). This aligns with CBIC's focus on systematic investigation and risk mitigation in healthcare-associated infection events. CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III: Prevention and Control of Infectious Diseases, which includes identifying sources of contamination in healthcare settings. CBIC Examination Content Outline, Domain V: Management and Communication, which emphasizes root cause analysis during outbreak investigations. CDC Guidelines for Safe Medication Compounding (2022), which recommend identifying contamination sources as the first step in a recall process.
Question 38
An infection preventionist is providing education to a group of medical device reprocessing staff on critical steps in cleaning instruments. Which of the following actions is recommended while using washer-disinfector?
Correct Answer: C
Best practices for using a washer-disinfector includedisassembling instrumentsandopening hinged instrumentsto ensure proper cleaning and decontamination. * TheAPIC Textexplains: "Open hinged instruments and disassemble all instruments... Confirm that spray will be able to reach all loaded items without impedance." * This ensures water and detergents reach all surfaces. Avoid stacking instruments and ensure proper placement to allow full cleaning. References: APIC Text, 4th Edition, Chapter 108 - Sterile Processing
Question 39
During an outbreak of ventilator-associated pneumonia (VAP), the infection preventionist should FIRST:
Correct Answer: A
* Reviewing compliance with VAP prevention bundles (e.g., head-of-bed elevation, oral care, sedation breaks) is the first step in outbreak control. * Preemptive antibiotics (B) are not recommended due to antibiotic resistance risks. * Negative pressure rooms (C) are not required for VAP. * Ventilator circuit cultures (D) do not guide patient management. CBIC Infection Control References: * APIC Text, "VAP Prevention Measures," Chapter 11.
Question 40
When describing the differences between colonization and infection, the infection preventionist should define colonization as
Correct Answer: C
The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly distinguishes colonization from infection, a foundational concept in infection prevention and healthcare epidemiology. Colonization is defined as the presence and multiplication of microorganisms on or within a host without tissue invasion, damage, or clinical signs of disease. Individuals who are colonized do not exhibit symptoms and typically do not mount an inflammatory response. Option C accurately reflects this definition and is the correct answer. Colonized organisms may be part of normal flora or may be potentially pathogenic organisms such as Staphylococcus aureus or multidrug- resistant organisms. Although colonization does not cause illness, colonized individuals can serve as reservoirs for transmission and may later develop infection if host defenses are compromised. Option A is incorrect because tissue invasion, even without visible damage, represents infection rather than colonization. Option B describes infection caused by normal flora with an inflammatory response. Option D includes cellular change, which indicates tissue response and therefore infection. For the CIC exam, it is essential to understand that colonization involves microbial presence without host response, while infection requires tissue invasion and a corresponding inflammatory or immune reaction. This distinction is critical for surveillance definitions, isolation decisions, antimicrobial stewardship, and patient education.